Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events
Authors
Keywords
Adverse event management, Expert opinion, Gastrointestinal events, Idiopathic pulmonary fibrosis, Photosensitivity, Pirfenidone, Respiratory, Safety, Skin-related events
Journal
ADVANCES IN THERAPY
Volume 31, Issue 4, Pages 375-391
Publisher
Springer Nature
Online
2014-03-18
DOI
10.1007/s12325-014-0112-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Photosafety assessments on pirfenidone: Photochemical, photobiological, and pharmacokinetic characterization
- (2013) Yoshiki Seto et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Real world experiences: Pirfenidone is well tolerated in patients with idiopathic pulmonary fibrosis
- (2013) Nazia Chaudhuri et al. RESPIRATORY MEDICINE
- Idiopathic Pulmonary Fibrosis
- (2012) Roland M. du Bois et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Adverse Events of Pirfenidone for the Treatment of Pulmonary Fibrosis: A Meta-Analysis of Randomized Controlled Trials
- (2012) Chunguo Jiang et al. PLoS One
- Gastroesophageal Reflux Therapy Is Associated with Longer Survival in Patients with Idiopathic Pulmonary Fibrosis
- (2011) Joyce S. Lee et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- The rising incidence of idiopathic pulmonary fibrosis in the UK
- (2011) V. Navaratnam et al. THORAX
- Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
- (2010) Brett Ley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pirfenidone: an anti-fibrotic therapy for progressive kidney disease
- (2010) Monique E Cho et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Pirfenidone in idiopathic pulmonary fibrosis
- (2009) H. Taniguchi et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adults
- (2009) C.M. Rubino et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Epidemiology of interstitial lung diseases in Greece
- (2009) A. Karakatsani et al. RESPIRATORY MEDICINE
- Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
- (2008) Hisashi Oku et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of three anti-TNF-α drugs: Etanercept, infliximab and pirfenidone on release of TNF-α in medium and TNF-α associated with the cell in vitro
- (2008) K.J. Grattendick et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Idiopathic pulmonary fibrosis
- (2008) Eric B Meltzer et al. Orphanet Journal of Rare Diseases
- Pirfenidone inhibits the expression of HSP47 in TGF-β1-stimulated human lung fibroblasts
- (2007) Seiko Nakayama et al. LIFE SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started